Kiromic BioPharma, Inc. (KRBP)
OTCMKTS: KRBP · Delayed Price · USD
3.110
+0.030 (0.97%)
May 17, 2024, 12:41 PM EDT - Market closed

Kiromic BioPharma Market Cap

Kiromic BioPharma has a market cap or net worth of $4.01 million as of May 17, 2024. Its market cap has decreased by -39.30% in one year.

Market Cap
4.01M
Enterprise Value
13.91M
1-Year Change
-39.30%
Ranking
n/a
Category
Stock Price
$3.11

Market Cap Chart

Since the IPO on October 16, 2020, Kiromic BioPharma's market cap has decreased from $88.00M to $4.01M, a decrease of -95.45%. That is a compound annual growth rate of -65.42%.

History

DateMarket Cap% Change
Sep 13, 20231.70M-10.53%
Sep 12, 20231.90M5.56%
Sep 11, 20231.80M-
Sep 8, 20231.80M-
Sep 7, 20231.80M-5.26%
Sep 6, 20231.90M-13.64%
Sep 5, 20232.20M4.76%
Sep 1, 20232.10M-4.55%
Aug 31, 20232.20M4.76%
Aug 30, 20232.10M-8.70%
Aug 29, 20232.30M-
Aug 28, 20232.30M9.52%
Aug 25, 20232.10M-4.55%
Aug 24, 20232.20M-4.35%
Aug 23, 20232.30M-8.00%
Aug 22, 20232.50M-3.85%
Aug 21, 20232.60M-
Aug 18, 20232.60M-3.70%
Aug 17, 20232.70M-
Aug 16, 20232.70M-3.57%
Aug 15, 20232.80M-
Aug 14, 20232.80M27.27%
Aug 11, 20232.20M-4.35%
Aug 10, 20232.30M-
Aug 9, 20232.30M-
View and export this data all the way back to 2020. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly 747.99B
Novo Nordisk 584.51B
UnitedHealth Group 476.19B
Johnson & Johnson 367.43B
Merck & Co. 333.65B
AbbVie 289.23B
AstraZeneca 238.64B
Thermo Fisher 228.66B
Market Cap Rankings